People · Operator
Named in public records as an officer, director or promoter · active 2009–2011 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Spartan Bioscience Inc. | — | Biotechnology | Pre-Seed | $260K | $6.1M | 2009 |
John Lem at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Lem on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Abrams | 1 | 6 |
| Michael Stork | 1 | 3 |
| Mark Houghting | 1 | 1 |
| Jamie Spiegelman | 1 | 1 |
| Ken Paige | 1 | 1 |
| Lawrence D'Andrea | 1 | 1 |
| Paul Markell | 1 | 1 |
| Paul Lem | 1 | 1 |
| Alan Shayanpour | 1 | 1 |
| Mark Kershey | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.